About

Sussan-Mari’s master research focused on the use of in silico molecular docking and synthesis to design libraries of anti-cholinergic agents and potential NMDA agonists as neuroprotective agents for the treatment of Alzhimer’s and Parkinson’s disease.

Dissertation

The design and synthesis of potential acetylcholinesterase inhibitors and NMDA antagonists as neuroprotective agents

Conferences

  1. 47th IUPAC World Chemistry Congress, Paris, France, July, 2019: Synthesis of novel Alzheimer’s disease drugs based on a pyrazole core, S. Botha*, D.L. Riley, J.-L. Panayides